Commodore Capital LP

Q3 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
37
Total value ($000)
$1,290,642
Net value change ($000)
-388,323 (-23.1%)
New positions
11
Sold out positions
7
Turnover %
35.0%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
DAMORA THERAPEUTICS INC 41,262 NEW
SRZN 28,479 NEW
KORSANA BIOSCIENCES INC 28,065 NEW
SGMT 27,246 NEW
ADARX PHARMACEUTICALS INC 25,136 NEW
ENTXW 21,397 NEW
ATTOVIA THERAPEUTICS INC 19,882 NEW
AGEN 19,715 NEW
RESEARCH ALLIANCE CORP IV 5,785 NEW
JATT III ACQUISITION CORP 4,408 NEW
Top Reduces (Value $000, Stocks/ETFs)
COGT -77,530 -65.7%
TNGX -70,335 -100.0%
DFTX -67,438 -71.7%
EYPT -65,780 -100.0%
GLTO -50,433 -100.0%
AMLX -43,274 -42.6%
ALKERMES PLC -40,675 -25.9%
ASMB -28,033 -72.1%
TYRA -22,162 -37.0%
CATX -21,608 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type